有机朗肯循环在多品位余热发电中的应用

低温余热的充分利用能够有效提高能源的利用效率、降低生产企业的能耗。本文以含硫天然气净化厂生产过程产生的余热为研究对象，对余热资源品位、余热回收潜能进行了分析和评价。通过对不同的余热发电方案进行分析对比，提出了以有机朗肯循环（ORC）为基础的多品位余热发电方案（MG-ORC），并对该发电方案进行了热力学分析。借助正交实验手段和多目标优化方法，对不同循环工质条件下MG-ORC发电方案的性能进行了对比分析，结果表明：工质R-600较其余4种工质表现出更优的综合性能，MG-ORC发电系统热效率为17.7%，净输出功率约2600kW。MG-ORC发电方案能够有效合理利用含硫天然气净化厂产生的余热，实现了能源的按质用能和梯级利用。     

CFD技术在降低裂解炉烧焦产物排放研究中的应用

对CFD技术的概念及分析方法进行了简要介绍。减少裂解炉烧焦产物排放的方法包括清焦罐分离和返炉膛烧焦。通过对这两种减少裂解炉烧焦产物排放技术的研究,描述了CFD技术在降低裂解炉烧焦产物排放研究中的应用。     

Sr对铸态Al-7Si-Mg合金组织和力学性能的影响

以砂型铸造Al-7Si-Mg合金为研究对象,研究了Sr含量对Al-7Si-Mg合金铸态组织和力学性能的影响。结果表明,添加Sr变质后,铸态Al-7Si-Mg合金的晶粒粗化,一次柱状晶生长明显。Sr变质Al-7Si-Mg合金中共晶Si形貌由针状或层片状组织向细化纤维状转变。当用0.06%的Sr变质时产生过变质现象,界面处Al-Si-Sr三元化合物逐渐增多,并产生富集。当Sr的含量为0.04%时,Al-7Si-Mg合金的抗拉强度和伸长率均达到最大,比未变质合金的抗拉强度和伸长率分别提高了8.4MPa、68.4%。     

ATP/GTP hydrolysis is required for oxazole and thiazole biosynthesis in the peptide antibiotic microcin B17

In the maturation of the Escherichia coli antibiotic Microcin B17, the product of the mcbA gene is modified posttranslationally by the multimeric Microcin synthetase complex (composed of McbB, C, and D) to cyclize four Cys and four Ser residues to four thiazoles and four oxazoles, respectively. The purified synthetase shows an absolute requirement for ATP or GTP in peptide substrate heterocyclization, with GTP one-third as effective as ATP in initial rate studies. The ATPase/GTPase activity of the synthetase complex is conditional in that ADP or GDP formation requires the presence of substrate; noncyclizable versions of McbA bind to synthetase, but do not induce the NTPase activity. The stoichiometry of ATP hydrolysis and heterocycle formation is 5:1 for a substrate that contains two potential sites of modification. However, at high substrate concentrations (>50Km) heterocycle formation is inhibited, while ATPase activity occurs undiminished, consistent with uncoupling of NTP hydrolysis and heterocycle formation at high substrate concentrations. Sequence homology reveals that the McbD subunit has motifs reminiscent of the Walker B box in ATP utilizing enzymes and of motifs found in small G protein GTPases. Mutagenesis of three aspartates to alanine in these motifs (D132, D147, and D199) reduced Microcin B17 production in vivo and heterocycle formation in vitro, suggesting that the 45 kDa McbD has a regulated ATPase/GTPase domain in its N-terminal region necessary for peptide heterocyclization.     

Osteopenia in children surviving brain tumours

Mature and post-translational precursor gastrin forms are growth factors for colorectal tumours. The immunogen Gastrimmune is composed of the amino terminus of gastrin-17 linked to diphtheria toxoid and raises antibodies in situ which neutralise amidated and glycine-extended gastrin-17. The aim of the study was to determine the effect of treatment with 5-fluorouracil(5-FU)/leucovorin on the antibody titres induced by Gastrimmune and the effect of combination therapy on the growth of the rat colon tumour DHDK12. Gastrimmune was administered to rats s.c. at 3 weekly intervals. The rat colon tumour line DHDK12 was injected into the abdominal wall of BDIX rats. Combinations of 5-FU/leucovorin were injected i.v. on days 1, 3 and 5, with the cycle repeated every 4 weeks. Antibody titres were measured by an ELISA technique. Antibody titres were followed for 40 weeks after Gastrimmune (500 microg.ml(-1)) immunization, with titres peaking between 10 and 20 weeks after a single immunisation and falling by week 30. At termination, no effect was observed on either the histological appearance of the gastro-intestinal tract or the proliferation of the colonic mucosa. Pre- and post-treatment with 5-FU/leucovorin (30 mg.kg(-1)) had no effect on the kinetics and level of antibody response to Gastrimmune. Gastrimmune (200 microg.ml(-1)) and 5-FU/leucovorin combinations (12.5 and 20 mg.kg(-1)) increased the therapeutic effects on the in vivo growth of DHDK12 tumors when compared to the agents given singly. Gastrimmune immunisation may be a therapeutic option for the treatment of colorectal cancer in combination with 5-FU/leucovorin.     

Lens transmission by fluorophotometry after brachytherapy and thermotherapy of choroidal melanoma

We studied the effect of transpupillary thermotherapy (TTT) by a diode laser at 810 nm combined with episcleral ruthenium-106 plaque treatment (106Ru) on lens transparency in patients with choroidal melanoma. Lens transmission of blue-green light was measured by fluorophotometry in 17 patients treated with 106Ru treatment and TTT (measured 0.36 years after treatment), 12 patients treated with 106Ru alone (measured 19 years after treatment) and 25 age-matched healthy controls. Differences in lens transmission were not significant between treated and untreated fellow eyes (p > 0.15) nor between patient and control eyes (p > 0.25). TTT of choroidal melanoma combined with 106Ru plaque irradiation did not have a significant effect on the lens transparency up to 6 years after treatment.